April 30, 2025
Apertura Gene Therapy and Rett Syndrome Research Trust Collaborate to Pioneer Advanced Genetic Medicines for Rett Syndrome Using TfR1-Targeted AAV Capsid
New York, NY and Trumbull, CT, April 30, 2025 – Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy solutions, ...